ABL Bio Inc. (298380.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap10.77T
Enterprise Value10.71T
P/E Ratio-210.74
PEG Ratio-5.39
Price/Sales Ratio47.05
Price/Book Ratio23.32
Enterprise/Revenue45.6
Enterprise/EBITDA-171.82

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.27
Operating Margin-0.32
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.14

Income Statement

Revenue79.35B
Revenue/Share1,627.38
Gross Profit45.85B
EBITDA-36.94B
Net Income-37.88B
Diluted EPS-703.38

Balance Sheet

Total Cash188.78B
Total Cash/Share3,401.42
Total Debt55.49B
Total Debt/Equity0.31
Current Ratio1.7
Book Value Per Share3,303.42

Price History

52-Week Change16.23
52-Week High257,500
52-Week Low63,300
Moving Average 50 Days107,334
Moving Average 200 Days149,902.5

Statistics

Average Volume521,674
Shares Outstanding55.99M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD